These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29623831)

  • 1. Proteomics Approach for Biomarker Research in Major Depression: Antidepressant Effects.
    Huang TL; Lo LH
    Curr Drug Metab; 2018; 19(6):502-512. PubMed ID: 29623831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
    Preece RL; Han SYS; Bahn S
    Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in major depressive disorder: the role of mass spectrometry.
    Woods AG; Iosifescu DV; Darie CC
    Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker discovery and applications for foods and beverages: proteomics to nanoproteomics.
    Agrawal GK; Timperio AM; Zolla L; Bansal V; Shukla R; Rakwal R
    J Proteomics; 2013 Nov; 93():74-92. PubMed ID: 23619387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
    Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
    Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.
    Gadad BS; Jha MK; Czysz A; Furman JL; Mayes TL; Emslie MP; Trivedi MH
    J Affect Disord; 2018 Jun; 233():3-14. PubMed ID: 28709695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
    Lin E; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression.
    Huang TL; Cho YT; Su H; Shiea J
    Clin Chim Acta; 2013 Sep; 424():175-81. PubMed ID: 23778025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.
    Jentsch MC; Van Buel EM; Bosker FJ; Gladkevich AV; Klein HC; Oude Voshaar RC; Ruhé EG; Eisel UL; Schoevers RA
    Biomark Med; 2015; 9(3):277-97. PubMed ID: 25731213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteomics and biomarkers for detection of endometrial carcinoma].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Aug; 74(4):274-8. PubMed ID: 20564981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers predicting antidepressant treatment response: how can we advance the field?
    Labermaier C; Masana M; Müller MB
    Dis Markers; 2013; 35(1):23-31. PubMed ID: 24167346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-γ Agonists for the Treatment of Major Depression: A Review.
    Colle R; de Larminat D; Rotenberg S; Hozer F; Hardy P; Verstuyft C; Fève B; Corruble E
    Pharmacopsychiatry; 2017 Mar; 50(2):49-55. PubMed ID: 27978584
    [No Abstract]   [Full Text] [Related]  

  • 17. From proteomics to prescription-the search for COPD biomarkers.
    Nicholas BL; O'Connor CD; Djukanovic R
    COPD; 2009 Aug; 6(4):298-303. PubMed ID: 19811390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-based immune-endocrine biomarkers of treatment response in depression.
    Chan MK; Cooper JD; Bot M; Birkenhager TK; Bergink V; Drexhage HA; Steiner J; Rothermundt M; Penninx BW; Bahn S
    J Psychiatr Res; 2016 Dec; 83():249-259. PubMed ID: 27693950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.